Filter posts

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Treating and Curing Disease Through Human Genome Editing

DNA defines who we are. And like anything else, sometimes there are mistakes – mutations …

Don't Leave the Highly Prevalent Chronic Diseases Behind

There is a lot to be excited about in biotech right now as we are …

Anything Could Happen at #BIO2018 Start-up Stadium

Last year Jerry Feitelson was accepted into BIO’s Start-up Stadium at the annual BIO International …

Notable Limitations of the Latest Drug Pricing Report

In a new report, Sen. Claire McCaskill, the ranking Democratic lawmaker on the Senate Homeland …

National Nutrition Month: The Promise of Gene Editing

One of the leading voices at the intersection of cooking and nutrition is Monica Reinagel …

#MakeHistory: Highlighting History | Taiwan

As one of the many economies inspired by the 1980s Biotech Revolution, Taiwan has adapted …

New Report Series Launched on The State of Innovation in Highly Prevalent Chronic Diseases

BIO’s Industry Analysis team has released its first report in a new series on the …

Patients Are at Core of Personalized Medicine Era

This week the Patient and Health Advocacy Summit concluded its sixth consecutive year, bringing hundreds …

Antimicrobial Resistance – 2017 BIO Investor Forum to Address Current Status

Alarm bells have been sounding for some time that deadly infections are developing resistance to …